Health Care — Alle selskaper

Retractable Technologies Inc

The company's capital structure is characterized by a low debt-to-equity ratio of 0.01, indicating minimal leverage. Its liquidity position is supported by $2.77 million in cash and equivalents, wi…

Picard Medical, Inc.

Structure and Liquidity Picard Medical, Inc. has a negative total equity of -$1.45 million and a current ratio of 0.75, indicating that current liabilities exceed current assets. The company's liqu…

Dr Reddys Laboratories Ltd

Capital structure and liquidity metrics are unavailable for assessment. The financial snapshot required to evaluate balance sheet strength, cash flow, and leverage ratios was not provided in the in…

Serina Therapeutics, Inc.

Structure and Liquidity Serina Therapeutics has a market capitalization of $22.59 million with a price-to-book ratio of 1.28, indicating that the market values the company slightly above its book v…

Astrazeneca Plc

McKesson Corp

McKesson Corp maintains a capital structure characterized by significant leverage relative to its equity base. The company reports total equity of -2.17 billion USD, resulting in a negative debt-to…

Organigram Global Inc.

Capital structure and liquidity metrics are unavailable as the financial snapshot is missing. The market price is recorded at $0.939. Without balance sheet data, debt levels, cash positions, and cu…

Teva Pharmaceutical Industries Limited..

Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems develops and sells the Growth Direct platform for automated microbial quality control testing, generating revenue from system sales and related consumables. The company is cl…

Ptc Therapeutics, Inc.

PTC THERAPEUTICS, INC. (PTCT) is currently classified as Pharmaceuticals within Pharmaceuticals (Healthcare). Classification confidence: 0.93 (rule-based classification). Capital structure on the l…

Hstm.O

Healthstream maintains a conservative capital structure with zero debt, resulting in a debt-to-equity ratio of 0.0. The balance sheet shows total assets of $520.4 million against total equity of $3…

Elevance Health Inc

Elevance Health maintains a capital structure characterized by significant leverage, with long-term debt of $30.8 billion against total equity of $43.9 billion, resulting in a debt-to-equity ratio…

Beyond Air, Inc.

Beyond Air, Inc. (XAIR) is currently classified as Medical Devices within Medical Equipment & Supplies (Healthcare). Classification confidence: 0.70 (rule-based classification). Capital structure o…

FibroBiologics, Inc.

FibroBiologics, Inc. (FBLG) is currently classified as Pharmaceuticals within Pharmaceuticals (Healthcare). Classification confidence: 0.78 (rule-based classification). Capital structure on the lat…

MindWalk Holdings Corp.

Capital structure and liquidity metrics are unavailable as no financial snapshot data was provided for the latest normalized period. The current market price is recorded at 1.72 USD, but without ba…

Vor Biopharma Inc.

Vor Biopharma Inc. (VOR) is currently classified as Pharmaceuticals within Pharmaceuticals (Healthcare). Classification confidence: 0.78 (rule-based classification). Capital structure on the latest…

Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc. (KYTX) is currently classified as Pharmaceuticals within Pharmaceuticals (Healthcare). Classification confidence: 0.93 (rule-based classification). Capital structure on t…

Vivani Medical, Inc.

Vivani Medical, Inc. (VANI) is currently classified as Biotechnology within Biotechnology (Healthcare). Classification confidence: 0.81 (rule-based classification). Capital structure on the latest…

GE Healthcare Technologies Inc

GE Healthcare Technologies maintains a capital structure characterized by significant leverage, with long-term debt of $9.50 billion against total equity of $10.38 billion, resulting in a debt-to-e…

Vstm.O

Verastem Inc maintains a strong liquidity position with cash and equivalents of $204.99 million against total liabilities of $189.25 million, resulting in a debt-to-equity ratio of 0.0. The company…

POMDOCTOR Ltd

Ftre.O

Masimo Corp

Agios Pharmaceuticals, Inc.

AGIOS Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing therapies for serious diseases, currently generating limited revenue while incurring significant operating losses to…

Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. operates as a vertically integrated manufacturer of generic injectable pharmaceuticals, generating revenue through the production and sale of sterile drug products.…

Anika Therapeutics, Inc.

Anika Therapeutics, Inc. is a medical device company that generates revenue through the sale of medical equipment and supplies, primarily within the healthcare sector. The company is classified in…

BioCardia, Inc.

BioCardia, Inc. develops cell therapy systems for heart failure, generating no revenue while incurring significant R&D and SG&A expenses to advance clinical trials. The company is classified in the…

Becton Dickinson & Co

Becton, Dickinson and Company manufactures and distributes medical supplies, devices, diagnostic products, and biopharmaceutical manufacturing technologies, generating revenue through global sales…

Brookdale Senior Living Inc.

Brookdale Senior Living Inc. operates senior living communities, generating revenue primarily through resident fees and management fees for third-party properties. The company is classified in the…

Caris Life Sciences, Inc.

Caris Life Sciences provides molecular profiling services and pharma research and development solutions, generating revenue primarily through genomic testing and data analytics for oncology and pre…

Context Therapeutics Inc.

Context Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel therapies, primarily through asset acquisitions and internal research, with no current product revenue. The…

Champions Oncology, Inc.

Champions Oncology, Inc. operates as a clinical-stage biopharmaceutical company focused on drug discovery and development, generating revenue through its technology platforms and Software as a Serv…

Castle Biosciences Inc

Castle Biosciences is a molecular diagnostics company that generates revenue by providing test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus, atopic dermati…

CVS HEALTH Corp

CVS Health operates as a healthcare services company generating revenue through pharmacy benefit management, retail pharmacy operations, and health insurance products. The company is classified in…

Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company developing abuse-deterrent opioid formulations, specifically PF614 and PF614-MPAR, relying on third-party contract research orga…

Edwards Lifesciences Corp

Edwards Lifesciences Corp designs and manufactures medical devices for treating structural heart disease, generating revenue primarily through the sale of transcatheter and surgical heart valve sys…

HCA Healthcare, Inc.

HCA Healthcare operates a network of hospitals and healthcare facilities, generating revenue through patient services and medical care delivery. The company is classified in the Healthcare Equipmen…

ImageneBio, Inc.

ImageneBio, Inc. is a clinical-stage biopharmaceutical company developing IMG-007 for immunological and inflammatory indications, relying on future regulatory approvals and potential collaborations…

Liquidia Corp

Liquidia Corp develops and commercializes pulmonary hypertension therapies, generating revenue primarily through product sales and service agreements in the US market. The company operates in the P…

Medpace Holdings, Inc.

Medpace Holdings, Inc. operates as a contract research organization providing strategic, operational, and tactical regulatory guidance and specialized laboratory testing services to the pharmaceuti…

Mesa Laboratories Inc /co/

MESA LABORATORIES INC /CO/ operates as a provider of laboratory instruments, consumables, and clinical genomics services, generating revenue through organic expansion of its customer base and produ…

Tenet Healthcare Corp

Tenet Healthcare operates a network of hospitals and ambulatory care facilities, generating revenue primarily through patient services and contract terminations. The company is classified in the He…

Universal Health Services Inc

Universal Health Services Inc operates healthcare facilities, generating revenue through patient care services and facility management. The company is classified in the Healthcare Equipment & Suppl…

Adma.O

ADMA Biologics maintains a conservative capital structure with total equity of $477.3 million against total liabilities of $146.9 million, resulting in a debt-to-equity ratio of 0.15. The company h…

Adpt.O

Adaptive Biotechnologies maintains a capital structure characterized by significant leverage relative to its equity base, with total liabilities of $287.74 million against total equity of $218.79 m…

Brookdale Senior Living Inc

Brookdale Senior Living Inc presents a balance sheet characterized by significant leverage and negative equity. Total liabilities stand at $5.99 billion, exceeding total assets of $5.95 billion, re…

Capricor Therapeutics Inc

Capricor Therapeutics maintains a pristine balance sheet characterized by zero debt and substantial liquidity. The company holds $287.8 million in cash and equivalents against total liabilities of…

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals maintains a conservative capital structure characterized by zero debt and a debt-to-equity ratio of 0.0. The balance sheet reflects total assets of $1.13 billion against t…

Danaher Corp

Danaher maintains a capital structure characterized by a debt-to-equity ratio of 0.35, indicating moderate leverage relative to its equity base of $52.5 billion. The company holds total assets of $…

Denali Therapeutics Inc

Denali Therapeutics maintains a conservative capital structure characterized by zero debt and a strong equity base. The company holds $205.3 million in cash and equivalents against total liabilitie…

Gmed.K

Innv.O

Lfcr.O

Lifecore Biomedical Inc exhibits a highly leveraged capital structure characterized by significant debt burden relative to equity. The company reports total liabilities of $191.9 million against to…

Mrcg.De

Merck KGaA maintains a balanced capital structure with a debt-to-equity ratio of 0.42, indicating moderate leverage relative to its equity base of €28.59 billion. The company holds €2.14 billion in…

Ocul.O

Oculis maintains a robust liquidity position with $737.1 million in cash and equivalents against total liabilities of $153.7 million, resulting in a debt-to-equity ratio of 0.0. The company’s marke…

Pacific Biosciences of California Inc

Pacific Biosciences maintains a capital structure characterized by negligible debt, with a debt-to-equity ratio of 0.0. The balance sheet shows total assets of $784.1 million against total liabilit…

PTC Therapeutics Inc

PTC Therapeutics maintains a negative equity position of -205.3 million USD against total liabilities of 3.1 billion USD, resulting in a debt-to-equity ratio of -0.0. The balance sheet holds 984.6…

Simulations Plus Inc

Simulations Plus Inc maintains a conservative capital structure with zero debt, resulting in a debt-to-equity ratio of 0.0. The balance sheet shows total assets of $131.9 million against total liab…

Teva Pharmaceutical Industries Limited..

Teva Pharmaceutical Industries Limited operates with a capital structure characterized by significant leverage and tight liquidity metrics. The company reports total assets of $40.75 billion agains…

Oncology Institute Inc

Oncology Institute Inc presents a balance sheet characterized by negative equity and significant leverage. Total assets stand at $164.7 million, while total liabilities exceed assets at $180.4 mill…

Travere Therapeutics Inc

Travere Therapeutics maintains a capital structure characterized by zero debt, with a debt-to-equity ratio of 0.0. The balance sheet shows total assets of $605.2 million against total liabilities o…

Apyx Medical Inc

Apyx Medical maintains a capital structure characterized by significant leverage relative to its equity base, with a debt-to-equity ratio of 2.4. The balance sheet shows total assets of $66.84 mill…

Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals maintains a conservative capital structure with zero debt, resulting in a debt-to-equity ratio of 0.0. The balance sheet holds $743.3 million in cash and equivalents again…

Caribou Biosciences Inc

Caribou Biosciences maintains a debt-free capital structure with a debt-to-equity ratio of 0.0, supported by total equity of $122.2 million against total liabilities of $53.2 million. The company h…

Enovis Corp

Enovis Corp maintains a capital structure characterized by significant leverage, with long-term debt of $1.26 billion against total equity of $1.49 billion, resulting in a debt-to-equity ratio of 0…

Kids.O

Orthopediatrics Corp maintains a capital structure characterized by moderate leverage and negative net cash. The company holds $19.6 million in cash and equivalents against $99.8 million in long-te…

Cosmos Health Inc.

Cosmos Health Inc. operates as a software and IT services company, generating revenue through application software and related health-tech solutions, including distribution via Amazon UK. The compa…

Cytosorbents Corp

Cytosorbents Corp maintains a capital structure characterized by high leverage and negative net cash. The company holds $6.25 million in cash and equivalents against $16.67 million in long-term deb…

CVS Health Corp

CVS Health maintains a capital structure characterized by a debt-to-equity ratio of 0.0, indicating a leverage-free balance sheet relative to the reported equity base of $75.2 billion. The company…

ICU Medical Inc

ICU Medical maintains a capital structure characterized by significant leverage relative to equity, with a debt-to-equity ratio of 0.6. The company holds $1.27 billion in long-term debt against $2.…

Ocgn.O

OCGN.O exhibits a distressed capital structure characterized by negative total equity of -$12.2 million and total liabilities of $55.7 million exceeding total assets of $43.5 million. The company c…

Align Technology Inc

Align Technology maintains a conservative capital structure characterized by zero debt relative to equity, resulting in a debt-to-equity ratio of 0.0. The balance sheet holds $1.09 billion in cash…

Allogene Therapeutics Inc

Allogene Therapeutics maintains a conservative capital structure with zero debt, resulting in a debt-to-equity ratio of 0.0. The company holds $51.7 million in cash and equivalents against total li…

Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals maintains a conservative capital structure characterized by zero debt and substantial liquidity reserves. The balance sheet reports total assets of $4.97 billion against tot…

Alxo.O

ALX Oncology Holdings Inc. maintains a conservative capital structure characterized by minimal leverage and a strong equity base relative to its liabilities. The company reports total assets of $30…

Ambea.St

Ambea AB maintains a highly leveraged capital structure, with long-term debt of SEK 12.64 billion against total equity of SEK 5.20 billion, resulting in a debt-to-equity ratio of 2.43. The company…

Anika Therapeutics Inc

Anika Therapeutics maintains a conservative capital structure with zero debt, resulting in a debt-to-equity ratio of 0.0. The balance sheet holds $57.5 million in cash and equivalents against total…

Arvn.O

Arvinas maintains a conservative capital structure with negligible long-term debt of $400,000 against total equity of $433.9 million, resulting in a debt-to-equity ratio of 0.0. The company holds $…

Autolus Therapeutics PLC

Autolus Therapeutics maintains a capital structure characterized by zero debt, with a debt-to-equity ratio of 0.0. The balance sheet shows total assets of $589.1 million against total liabilities o…

Azenta Inc

Azenta Inc maintains a conservative capital structure with zero debt relative to equity, resulting in a debt-to-equity ratio of 0.0. The balance sheet reflects total assets of $2.06 billion against…

Bio Rad Laboratories Inc

Bio-Rad Laboratories maintains a conservative capital structure with total equity of $7.45 billion against total liabilities of $3.12 billion. The company holds $530 million in cash and equivalents…

Bristol-Myers Squibb Co

Bristol-Myers Squibb maintains a capital structure characterized by high leverage, with total liabilities of $71.53 billion against total equity of $18.47 billion, resulting in a debt-to-equity rat…

Boston Scientific Corp

Boston Scientific maintains a conservative capital structure with a reported debt-to-equity ratio of 0.0, indicating minimal leverage relative to its equity base of $24.2 billion. The company holds…

Candel Therapeutics Inc

Candel Therapeutics maintains a strong liquidity position with cash and equivalents of $70.1 million against total liabilities of $30.0 million, resulting in a debt-to-equity ratio of 0.0. The comp…

Cencora Inc

Cencora Inc maintains a highly leveraged capital structure, evidenced by a debt-to-equity ratio of 5.0 and total equity of $1.51 billion against total assets of $76.59 billion. The company holds $4…

Cosmos Health Inc

Cosmos Health Inc maintains a capital structure characterized by low leverage but significant liquidity constraints. The company reports total equity of $18.4 million against total liabilities of $…

Charles River Laboratories International Inc

Hrow.O

Harrow Inc. maintains a capital structure characterized by high leverage, with long-term debt of $250.0 million against total equity of $52.4 million, resulting in a debt-to-equity ratio of 4.77. T…

Incyte Corp

Incyte maintains a robust capital structure characterized by zero debt and substantial liquidity. The company holds $3.10 billion in cash and equivalents against total liabilities of $1.79 billion,…

Insmed Inc

Insmed Inc operates with a capital structure characterized by significant leverage relative to its equity base, holding $540.96 million in long-term debt against $738.98 million in total equity, re…

IQVIA Holdings Inc

IQVIA Holdings Inc maintains a capital structure characterized by significant leverage, with a debt-to-equity ratio of 2.14 and long-term debt totaling $13.88 billion against total equity of $6.50…

Ird.O

KORU Medical Systems Inc

KORU Medical Systems maintains a debt-free capital structure with a debt-to-equity ratio of 0.0, supported by $8.87 million in cash and equivalents against total assets of $28.20 million. The compa…

Lmri.O

Lumexa Imaging Holdings Inc maintains a capital structure characterized by significant leverage, with long-term debt of $876.96 million against total equity of $586.12 million, resulting in a debt-…

Moderna Inc

Moderna maintains a conservative capital structure with total equity of $8.65 billion against total liabilities of $3.69 billion, resulting in a debt-to-equity ratio of 0.07. The company holds $2.5…

Tsha.O

Taysha Gene Therapies maintains a strong liquidity position with $319.8 million in cash and equivalents against total liabilities of $96.4 million. The balance sheet shows total assets of $343.3 mi…

Vrex.O

VREX maintains a capital structure characterized by significant leverage relative to its equity base. The company holds $145 million in cash and equivalents against $366 million in long-term debt,…

Catheter Precision, Inc.

Catheter Precision maintains a capital structure characterized by significant leverage relative to its equity base, with a debt-to-equity ratio of 0.44. The company holds $88,000 in cash and equiva…

Viatris Inc

Viatris maintains a capital structure characterized by significant leverage, with long-term debt of $12.48 billion against total equity of $14.71 billion, resulting in a debt-to-equity ratio of 0.8…

Ahco.O

AHCO.O maintains a capital structure characterized by significant leverage, with long-term debt of $1.72 billion against total equity of $1.52 billion, resulting in a debt-to-equity ratio of 1.13.…

Teladoc Health Inc

Teladoc Health maintains a conservative capital structure with a debt-to-equity ratio of 0.0, indicating no long-term debt burden. The company holds $781.1 million in cash and equivalents against t…

Tenet Healthcare Corp

Tenet Healthcare Corp maintains a capital structure characterized by a reported debt-to-equity ratio of 0.0, which appears anomalous given total liabilities of $20.7 billion and total equity of $4.…

Alms.O

Alumis Inc maintains a conservative capital structure with zero debt, resulting in a debt-to-equity ratio of 0.0. The company holds $89.67 million in cash and equivalents against total liabilities…

Avr.O

AVR.O presents a distressed capital structure with negative total equity of -93,000 USD against total liabilities of 23,250,000 USD and total assets of 22,997,000 USD. The company reports a market…

Cardinal Health, Inc

Orka.O

The company maintains a pristine balance sheet with total assets of $37.86 million, composed almost entirely of $37.43 million in cash and equivalents. Total liabilities are minimal at $0.84 millio…

Achieve Life Sciences Inc

Achieve Life Sciences maintains a conservative capital structure characterized by zero debt and a strong liquidity position. The balance sheet reports total assets of $21.1 million against total li…

Alphatec Holdings Inc

Alphatec Holdings maintains a capital structure characterized by significant leverage, with long-term debt of $501.4 million against total equity of $12.4 million, resulting in a debt-to-equity rat…

Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for inflammatory and autoimmune diseases, primarily generating capital through equity…

Hrmy.O

Harmony Biosciences Holdings maintains a conservative capital structure with a debt-to-equity ratio of 0.17, indicating limited leverage relative to its equity base. The company holds substantial l…

Vrdn.O

Viridian Therapeutics maintains a conservative capital structure with zero debt relative to equity, resulting in a debt-to-equity ratio of 0.0. The company holds total assets of $899.4 million agai…

Baxter International Inc

(a) Capital Structure + Liquidity The company holds $1.97 billion in cash and equivalents against $9.44 billion in long-term debt, resulting in a net debt position. The debt-to-equity ratio stands…

Centene Corp

Centene Corp maintains a balanced capital structure with total equity of $19.95 billion against total liabilities of $56.69 billion, resulting in a debt-to-equity ratio of 0.87. The company holds $…

UnitedHealth Group Inc

UnitedHealth Group maintains a capital structure characterized by significant leverage, with long-term debt of $78.39 billion against total equity of $94.11 billion, resulting in a debt-to-equity r…

Vivani Medical Inc

Vivani Medical maintains a debt-free capital structure with a debt-to-equity ratio of 0.0, supported by total equity of $15.73 million and cash and equivalents of $16.23 million against total asset…

Agenus Inc

Agenus Inc operates with a capital structure characterized by negative total equity of -271.1 million USD and zero long-term debt, resulting in a debt-to-equity ratio of -0.0. The company holds min…

agilon health inc

Agilon Health maintains a capital structure characterized by minimal leverage, with long-term debt of $15.75 million against total equity of $126.73 million, resulting in a debt-to-equity ratio of…

Amphastar Pharmaceuticals, Inc

Amphastar Pharmaceuticals maintains a capital structure characterized by significant leverage relative to its equity base. The company reports total assets of $1.63 billion against total liabilitie…

ANI Pharmaceuticals Inc

ANI Pharmaceuticals maintains a balanced capital structure with total assets of $1.44 billion and total liabilities of $900 million. The company holds $286 million in cash and equivalents against $…

Alto Neuroscience Inc

Alto Neuroscience maintains a conservative capital structure characterized by minimal leverage and substantial liquidity. The company holds $176.5 million in cash and equivalents against total liab…

Bruker Corp

Bruker Corp maintains a capital structure characterized by significant leverage, with long-term debt of $1.85 billion against total equity of $2.46 billion, resulting in a debt-to-equity ratio of 0…

Conmed Corp

Conmed Corp maintains a conservative capital structure with a debt-to-equity ratio of 0.0, indicating no reported interest-bearing debt relative to equity. The company holds total assets of $2.33 b…

Cogent Biosciences Inc

Cogent Biosciences maintains a robust liquidity position with $242.19 million in cash and equivalents against total liabilities of $16.25 million, resulting in a debt-to-equity ratio of 0.0. The co…

Cooper Companies Inc

The company maintains a conservative capital structure with a debt-to-equity ratio of 0.3, indicating limited leverage relative to shareholder equity. Total liabilities stand at $4.16 billion again…

CorMedix Inc

CorMedix maintains a conservative capital structure with zero debt relative to equity, resulting in a debt-to-equity ratio of 0.0. The balance sheet reflects total assets of $826.1 million against…

Exelixis Inc

Exelixis maintains a robust capital structure characterized by zero debt and substantial liquidity. The company holds $482.5 million in cash and equivalents against total liabilities of $683.1 mill…

Indivior Pharmaceuticals Inc

Indivior maintains a negative equity position of -98 million USD against total liabilities of 1.3 billion USD, resulting in a debt-to-equity ratio of -2.96. The balance sheet shows 195 million USD…

Kodiak Sciences Inc

Kodiak Sciences maintains a capital structure characterized by zero debt, with a debt-to-equity ratio of 0.0. The balance sheet shows total assets of $351.5 million, funded by $157.4 million in tot…

Ligand Pharmaceuticals Inc

Ligand Pharmaceuticals maintains a conservative capital structure characterized by zero debt, resulting in a debt-to-equity ratio of 0.0. The balance sheet reflects total assets of $1.56 billion ag…

Lonza Group AG

Lonza Group AG maintains a capital structure characterized by significant leverage relative to equity, with a debt-to-equity ratio of 0.57 and long-term debt totaling CHF 4.54 billion against total…

Medpace Holdings Inc

Medpace maintains a conservative capital structure characterized by zero debt and substantial liquidity. The balance sheet reports total assets of $1.98 billion against total liabilities of $1.52 b…

Molina Healthcare Inc

Nuvation Bio Inc

Nuvation Bio maintains a capital structure characterized by low leverage and significant cash reserves relative to its market capitalization. The company holds $164.1 million in cash and equivalent…

Organon & Co

Organon & Co maintains a capital structure characterized by high leverage and limited equity cushion. The company reports total assets of $12.87 billion against total liabilities of $12.12 billion,…

Olma.O

Olema Pharmaceuticals maintains a conservative capital structure characterized by zero debt, resulting in a debt-to-equity ratio of 0.0. The balance sheet reflects total assets of $533.4 million ag…

Omeros Corp

Option Care Health Inc

Option Care Health maintains a capital structure characterized by significant leverage, with long-term debt of $1.15 billion against total equity of $1.33 billion, resulting in a debt-to-equity rat…

Pacs Group Inc

Pacs Group Inc maintains a capital structure characterized by a debt-to-equity ratio of 0.26, indicating moderate leverage relative to its equity base of $946.8 million. The company holds $197.0 mi…

Pennant Group Inc

Pennant Group maintains a capital structure characterized by a debt-to-equity ratio of 0.45, indicating moderate leverage relative to its equity base of $374.3 million. The company holds total liab…

Protagonist Therapeutics Inc

Protagonist Therapeutics maintains a conservative capital structure characterized by zero debt and a substantial cash position. The company holds $128.39 million in cash and equivalents against tot…

Ultragenyx Pharmaceutical Inc

Ultragenyx operates with a negative equity position of -80 million USD against total liabilities of 1.605 billion USD and total assets of 1.532 billion USD. The balance sheet reflects a debt-to-equ…

Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals maintains a capital structure characterized by significant leverage relative to its equity base, with a debt-to-equity ratio of 0.73. The company holds $54.3 million in cash…

Straumann Holding AG

Straumann Holding AG maintains a conservative capital structure with a debt-to-equity ratio of 0.19 and a current ratio of 2.21, indicating strong short-term liquidity coverage. The balance sheet s…

Sls.O

(a) Capital structure and liquidity present significant constraints for the firm. The balance sheet shows total assets of $6.2 million against total liabilities of $14.2 million, resulting in negat…

Tenx.O

Tenax Therapeutics maintains a conservative capital structure characterized by zero debt and a strong liquidity position. The balance sheet reports total assets of $104.2 million, with cash and equ…

Tndm.O

Tandem Diabetes Care maintains a capital structure characterized by significant leverage, with a debt-to-equity ratio of 2.0. Total liabilities stand at $725.9 million against total equity of $155.…